Advertisement

Topics

Companies Related to "Purdue Pharma Announces Strategic Investment Oncology" [Most Relevant Company Matches] RSS

09:32 EST 15th December 2018 | BioPortfolio

Here are the most relevant search results for "Purdue Pharma Announces Strategic Investment Oncology" found in our extensive corporate database of over 50,000 company records.

Showing "Purdue Pharma Announces Strategic Investment Oncology" Companies 1–25 of 4,100+

Extremely Relevant

Purdue Pharma, LP

Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on persistent pain. Headquartered in Stamford, CT, Purdue Pharma is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduep...


Purdue Pharma L.P.

Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on persistent pain. Headquartered in Stamford, CT, Purdue Pharma is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional informatio...

Relevant

Purdue Research Foundation

Purdue Research Foundation is responsible for Purdue University's technology-transfer program, the development of Purdue Research Park of West Lafayette, and the management of that park's business development services and flagship incubator. The Purdue Research Park is the largest university-affiliated research park in the United States. Its four locations...


Purdue Pharma L.P.,

Purdue is known for its pioneering research on a principal cause of human suffering: persistent pain. Purdue Pharma L.P., headquartered in Stamford, Connecticut, and independent associated companies in the U.S. are known for their pioneering research on a principal cause of human suffering: persistent pain. These associated companies have also applied their expertise to other therapeutic areas suc...

Strategia Holdings, LLC

Strategia Holdings, LLC, is based in the U.S. and oversees three biotech companies; Spirita Oncology, LLC, Mirata BioPharma, LLC, and Strategia Pharmaceuticals, LLC. Spirita focuses on oncology drug development in the US with E6201, a MEK1 inhibitor, as their flagship candidate focused on melanoma brain metastases. Mirata is a pre-clinical stage immuno-onc...

Mundipharma International Ltd

The Mundipharma International Group of Companies are privately owned associated companies and joint ventures covering the world’s pharmaceutical markets. The Group is particularly strong in analgesics, respiratory products, cardiovascular medicines, antiseptics and laxatives.We employ over 4000 people and have ex-company sales of over $800m of which 25% are from licensed products. Total sales of...

Archimedes Pharma Ltd

Archimedes Pharma is an international specialty pharmaceutical company focused on the oncology, pain, and critical care sectors. Archimedes Pharma is marketing an expanding portfolio of specialist products to hospital-based prescribers in Europe and has established commercial organizations in the UK, US, France, Germany, Ireland, and Spain.

Kiadis Pharma

Kiadis Pharma is an oncology focused biopharmaceutical company developing products that offer novel treatment options for terminally ill cancer patients addressing significant unmet medical needs. The key focus indication for Kiadis Pharma is the limitations and complications of hematopoietic stem cell transplantation procedures.

Dar Pharma

Dar Pharma is a Mexican enterprise that offers services to support the pharmaceutical and biotechnological industry for new products development. Dar Pharma offers consulting services in the clinical area, such as project management, clinical services; including strategic planning and implementation of clinical trials in the Mexican environment. As additional services, Dar Pharma provides regulato...

ENDOTIS PHARMA

ENDOTIS PHARMA a biopharmacteutical company in the field of Therapeutic Glycomics is dedicated to the discovery and the deveolpment of Small Glyco Drugs fior oncology and uinflammation

Onco360®, Oncology Pharmacy Solutions

With executive offices in New York City, Onco360 (http://onco360.com) is the largest independent provider of Oncology Pharmacy services in the country. Onco360 was founded in 2003 as OncoMed, The Oncology Pharmacy, to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals...

Purdue Biopharma

Purdue Biopharma L.P. is a research-oriented biopharmaceutical company which seeks to benefit patients by providing new treatments for cancer, infectious diseases and disorders of the immune system. As the Discovery Research arm of a growing and successful international Pharmaceutical organization, we are seeking highly motivated professionals to support our expansion in the Princeton, NJ area. ...

Solasia Pharma K.K.

Solasia Pharma K.K. (Tokyo, Japan) was formed in November 2006 by MPM Capital and Itochu Corporation to address unmet needs for important new Western oncology therapies throughout Asia. Our mission is to expedite patient access to unique oncology therapies through aggressive development and specialized commercialization throughout Japan, China and other As...

Astellas Pharma Inc.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. Astellas has approximately 15,000 employees worldwide. The organization is committed to becoming a global category leader in urology, immunology & infectious diseases, neuroscience, DM complications...

Gleacher & Company, Inc.

Gleacher & Company, Inc. (Nasdaq: GLCH) is an independent, full service investment bank that provides corporate and institutional clients with strategic, research-based investment opportunities, capital raising, and financial advisory services, including merger and acquisition, restructuring, recapitalization, and strategic alternative analysis, as well as...

Santaris Pharma A/S

Santaris Pharma is a science-based product-driven biopharmaceutical company focused on oncology. Our mission is to discover, develop and commercialise new and better drugs drugs for the treatment of cancer.We seek to fulfil this mission through an integrated business strategy comprising:Rapid development of own products based on our pioneering RNA antagonist drug platformStructuring of corporate p...

Novelos Therapeutics, Inc.

Novelos Therapeutics, Inc. is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis. Novelos is seeking to build a pipeline through licensing or acquiring clinical stage compounds or technologies for oncology indications. Our lead compound, NOV-002, has been administered to approximately ...

Purdue Products L.P. Line of Laxatives

Senokot® Tablets and Colace® Capsules have been recommended by doctors and pharmacists for more than 50 years for effective, gentle and safe relief from occasional constipation. Colace® Capsules, the #1 recommended stool softener brand by doctors and pharmacists, relieves occasional constipation that may be associated with certain medical conditions. Senokot-S® Tablets provide gentle, yet effe...

ResQ Pharma, Inc.

ResQ Pharma, Inc., is a biopharmaceutical company created to ensure access to reliable, global use of LRT, a treatment for various lipophilic drug overdoses and poisonings. For more information on ResQ Pharma, please visit www.LipidRescue.com. We are members of iBIO’s PROPEL, EnterpriseWorks Chicago, Chicago Founders Circle, The B...

Starr Investment Holdings, LLC

Starr Investment Holdings, LLC ("SIH") is a multi-billion dollar New York-based investment adviser that leverages the Starr Companies' unique duration-agnostic capital together with that of select institutions and family offices. SIH invests in privately-held technology-enabled services businesses with a particular focus on industries such as financial ser...

Celtic Pharmaceutical Holdings L.P.

Celtic Pharmaceutical Holdings L.P. is a global private equity investment firm focused on the biotechnology and pharmaceutical industries. Celtic Pharma was founded by Stephen Evans-Freke and John Mayo, CBE, and is based in Bermuda, with offices in New York and London. Celtic Pharma acquires and invests in late stage pharmaceutical programs and drives these programs through the final stages of...

External Pharma Inc

External Pharma, Inc. provides preclinical drug discovery and development support to pharmaceutical and biotech companies as fee for service or in collaboration with a partner. Our main focus is to evaluate drug candidates and targets for neurological and psychiatric indications. External Pharma represents the next generation of CROs - highly experienced drug development scientists working in a st...

Polyphenon Pharma

Polyphenon Pharma is a privately held subsidiary of the Japanese company, Mitsui Norin Co., Ltd., which discovered and manufactures the botanical drug Polyphenon E. Headquartered in New York, NY, Polyphenon Pharma focuses on the clinical development of Polyphenon E across a broad spectrum of therapeutic areas in which it has potential activity, including infectious disease/virology, urology, ...

The Cockrell Group

The Cockrell Group, Inc. is a strategic investor relations and corporate access firm focused on small-to-midcap companies in healthcare. It aligns a company's strategic goals to an institution's investment thesis and fundamentals to create a sound, long-term investment objective. The company also advises companies in various areas, including private and pr...

Heidelberg Pharma GmbH

When working at Boehringer Mannheim (now Roche Diagnostics) from 1987 to 1999, the founders of Heidelberg Pharma, Dr. Dieter Herrmann and Dr. Hans-Georg Opitz, developed technologies and know-how that enable to overcome medical limitations of many well established drugs and pipeline compounds still under development. In connection with a management buy-out, the founders of Heidelberg Pharma took a...


More From BioPortfolio on "Purdue Pharma Announces Strategic Investment Oncology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks